Estrogen keeps your artery walls flexible and keeps your liver clearing LDL out of the blood 1. When the ovaries stop making it, that stops at once. Arteries stiffen within a year 2, LDL and ApoB jump in a tight window around the final period rather than drifting up slowly 3, and fat shifts from hips to belly by roughly 10% a year at stable weight 4.
The advantage women hold over same-age men erodes after the final period and is mostly gone by the late sixties 5. Proof it's menopause and not just age: women who lose their ovaries early, or reach menopause before 45, get the same trajectory in a younger decade, with more coronary disease, stroke, and heart failure 6. And frequent hot flushes track with more cardiovascular events, independent of the usual risk factors 7.
Get a proper cardiovascular baseline at the transition, then again a year or two after your last period. Most of it is routine primary care, and where numbers cross a threshold the ordinary drugs apply, just started in your early fifties instead of your late sixties.
The hormone-therapy question turns on timing. Started within 10 years of your final period, before 60, it is broadly safe and probably mildly protective; started first in your late sixties, it harms 10. The scary 2002 headline came from a much older cohort; the re-analysis put the harm in the late starters 11. In the window and having symptoms, the heart conversation is on your side 12.
Why acting now beats acting later. The window is leveraged because the artery wall is still flexible and the plaque hasn't had years to organise 5.
- Months: a baseline you can act on, and a clear yes-or-no on hormone therapy.
- A year or two: the trajectory bends; training here holds off the belly-fat shift 9.
- A decade on: the slope toward stroke and heart failure was bent in your early fifties, when it was cheapest to bend.
Push earlier and harder if menopause came before 45 or your ovaries were removed 6; if your pregnancies included preeclampsia, gestational diabetes, or preterm birth 12; or if you're Black, where blood pressure climbs steeper 14.
- 1Mendelsohn ME, Karas RH (2005). Molecular and cellular basis of cardiovascular gender differences. Science. link
- 2Samargandy S, Matthews KA, Brooks MM, Barinas-Mitchell E, Magnani JW, Janssen I, El Khoudary SR (2020). Arterial stiffness accelerates within 1 year of the final menstrual period: the SWAN Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology. link
- 3Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K (2009). Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology. link
- 4Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, Cauley JA, Finkelstein JS, Jiang SF, Karlamangla AS (2019). Changes in body composition and weight during the menopause transition. JCI Insight. link
- 5El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, Allison MA (2020). Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention. A Scientific Statement From the American Heart Association. Circulation. link
- 6Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P (2019). Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. link
- 7Thurston RC, Aslanidou Vlachos HE, Derby CA, Jackson EA, Brooks MM, Matthews KA, Harlow S, Joffe H, El Khoudary SR (2021). Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. Journal of the American Heart Association. link
- 8Lobo RA, Davis SR, De Villiers TJ, Gompel A, Henderson VW, Hodis HN, Lumsden MA, Mack WJ, Shapiro S, Baber RJ (2014). Prevention of diseases after menopause. Climacteric. link
- 9Karvinen S, Jergenson MJ, Hyvärinen M, Aukee P, Tammelin T, Sipilä S, Kovanen V, Kujala UM, Laakkonen EK (2019). Menopausal Status and Physical Activity Are Independently Associated With Cardiovascular Risk Factors of Healthy Middle-Aged Women. Frontiers in Endocrinology. link
- 10NAMS (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. link
- 11Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. link
- 12Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H, Kunadian V, Laan E, Lambrinoudaki I, Maclaran K (2021). Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. European Heart Journal. link
- 13El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, Allison MA (2019). HDL and the menopause. Current Opinion in Lipidology. link
- 14Samargandy S, Matthews KA, Brooks MM, Barinas-Mitchell E, Magnani JW, Thurston RC, El Khoudary SR (2022). Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter? Circulation Research. link